XML 33 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Restructuring, Impairment and Costs of Terminated Program, and Impairment of Goodwill (Tables)
6 Months Ended
Jun. 30, 2023
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring, Impairment and Other Costs of Terminated Program Restructuring, impairment and other costs of terminated program pertaining to the 2022 Restructuring Plan includes the following (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Clinical trial expense, other third-party and employee costs for the wind down of the bempegaldesleukin program$1,356 $20,408 $2,954 $20,408 
Severance and benefits expense— 27,750 — 27,750 
Impairment of right-of-use assets and property, plant and equipment13,255 57,321 13,255 57,321 
Contract termination and other restructuring costs— 566 878 2,041 
Restructuring, impairment and costs of terminated program$14,611 $106,045 $17,087 $107,520 
Restructuring, impairment and other costs of terminated program pertaining to the 2023 Restructuring Plan includes the following (in thousands):
Three Months Ended June 30, 2023Six Months Ended June 30, 2023
Severance and benefit expense$1,943 $7,426 
Impairment of right-of-use assets and property, plant and equipment— 13,200 
Contract termination and other restructuring costs— 34 
Restructuring, impairment and costs of terminated program$1,943 $20,660 
The following table provides details regarding the severance and benefit expense for the three and six months ended June 30, 2023 pursuant to the 2023 Restructuring Plan and a reconciliation of the severance and benefits liability for the three and six months ended June 30, 2023 pursuant to the 2022 and 2023 Restructuring Plans, which we report within accrued expenses on our Condensed Consolidated Balance Sheet (in thousands):
Six Months Ended June 30, 2023
2023 Restructuring Plan2022 Restructuring PlanTotal
Liability balance as of December 31, 2022$— $3,299 $3,299 
Expense recognized during the period5,483 — 5,483 
Payments during the period— (3,299)(3,299)
Liability balance as of March 31, 2023$5,483 $— $5,483 
Expense recognized during the period1,943 — 1,943 
Payments during the period(6,624)— (6,624)
Liability balance as of June 30, 2023$802 $— $802 
Additionally, we recorded an impairment expense primarily for software which we planned to abandon and certain excess equipment based on the estimated income from selling such assets. We recorded impairment charges as follows (in thousands):
Three and Six months ended June 30, 2022
Property, Plant and EquipmentOperating Lease Right-of-Use AssetsTotal
Net book value of impaired facilities before write-off$16,348 $70,920 $87,268 
Less: Fair value of impaired facilities — Level 3 of Fair Value Hierarchy(6,976)(28,091)(35,067)
Impairment expense for facilities9,372 42,829 52,201 
Impairment of other property, plant and equipment5,120 — 5,120 
Total impairment of right-of-use assets and property, plant and equipment$14,492 $42,829 $57,321 
The following table presents a reconciliation of the non-cash impairment charges we recorded for these long-lived assets for the three and six months ended June 30, 2023 (in thousands):
Three Months Ended June 30, 2023
Property, Plant and EquipmentOperating Lease Right-of-Use AssetsTotal
Net book value of impaired facilities before write-off$2,092 $16,392 $18,484 
Less: Fair value of impaired facilities — Level 3 of Fair Value Hierarchy(529)(4,700)(5,229)
Total impairment of right-of-use assets and property, plant and equipment1,563 11,692 13,255 
Six Months Ended June 30, 2023
Property, Plant and EquipmentOperating Lease Right-of-Use AssetsTotal
Net book value of impaired facilities before write-off$7,206 $44,826 $52,032 
Less: Fair value of impaired facilities — Level 3 of Fair Value Hierarchy(3,843)(23,434)(27,277)
Impairment expense for facilities3,363 21,392 24,755 
Impairment of other property, plant and equipment1,700 — 1,700 
Total impairment of right-of-use assets and property, plant and equipment$5,063 $21,392 $26,455